-
EP3214171
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3214171
| EP3214171 - PLACENTA-DERIVED CELLS EXCRETING C3 OR C1R COMPLEMENT AND COMPOSITION CONTAINING SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.10.2020 Database last updated on 15.06.2024 | |
| Former | Examination is in progress Status updated on 05.03.2019 | ||
| Former | Request for examination was made Status updated on 04.08.2017 | ||
| Former | The international publication has been made Status updated on 10.05.2017 | Most recent event Tooltip | 16.10.2020 | Application deemed to be withdrawn | published on 18.11.2020 [2020/47] | Applicant(s) | For all designated states Sungkwang Medical Foundation 566 Nonhyeon-ro Gangnam-gu Seoul 06135 / KR | [2017/36] | Inventor(s) | 01 /
MOON, Ji Sook 302-1102 1218 Yangjae-daero Songpa-gu Seoul 05649 / KR | 02 /
KIM, Chul 2-905 164 Gwanak-daero Dongan-gu Anyang-si Gyeonggi-do 13953 / KR | 03 /
PARK, Ji Min Rm.401 66 Geojecheon-ro 124beon-gil Yeonje-gu Busan 47541 / KR | 04 /
BAE, Sang Hun Rm.202 31 Guwol-ro 52beon-gil Namdong-gu Incheon 21553 / KR | 05 /
KIM, Joopyung 611-1802, 265, Baekhyeon-ro Bundang-gu Seongnam-si Gyeonggi-do 13600 / KR | 06 /
KIM, Hyun Sook 204-1101, 35, Gwangpyeong-ro 34-gil Gangnam-gu Seoul 06362 / KR | 07 /
KIM, Ok Joon 110-1604, 332, Eonju-ro Gangnam-gu Seoul 06216 / KR | [2017/36] | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [2017/36] | Application number, filing date | 15855075.6 | 29.10.2015 | [2017/36] | WO2015KR11493 | Priority number, date | KR20140148457 | 29.10.2014 Original published format: KR 20140148457 | [2017/36] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016068616 | Date: | 06.05.2016 | Language: | KO | [2016/18] | Type: | A1 Application with search report | No.: | EP3214171 | Date: | 06.09.2017 | Language: | EN | [2017/36] | Search report(s) | International search report - published on: | KR | 06.05.2016 | (Supplementary) European search report - dispatched on: | EP | 12.06.2018 | Classification | IPC: | C12N5/0775, A61K35/12, A61P25/00, A61P27/02 | [2017/36] | CPC: |
A61P25/28 (EP,US);
A61K35/545 (US);
A61K35/12 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/36] | Title | German: | C3- ODER C1R-KOMPLEMENT AUSSCHEIDENDE ZELLEN AUS DER PLAZENTA UND ZUSAMMENSETZUNG DAMIT | [2017/36] | English: | PLACENTA-DERIVED CELLS EXCRETING C3 OR C1R COMPLEMENT AND COMPOSITION CONTAINING SAME | [2017/36] | French: | CELLULES DÉRIVÉES DU PLACENTA, EXCRÉTANT LE COMPLÉMENT C3 OU C1R ET COMPOSITION LES CONTENANT | [2017/36] | Entry into regional phase | 29.05.2017 | Translation filed | 29.05.2017 | National basic fee paid | 29.05.2017 | Search fee paid | 29.05.2017 | Designation fee(s) paid | 29.05.2017 | Examination fee paid | Examination procedure | 29.05.2017 | Examination requested [2017/36] | 29.05.2017 | Date on which the examining division has become responsible | 04.01.2019 | Amendment by applicant (claims and/or description) | 07.03.2019 | Despatch of a communication from the examining division (Time limit: M06) | 13.09.2019 | Reply to a communication from the examining division | 12.12.2019 | Despatch of a communication from the examining division (Time limit: M06) | 23.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/47] | 14.07.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/47] | Fees paid | Renewal fee | 26.10.2017 | Renewal fee patent year 03 | 31.10.2018 | Renewal fee patent year 04 | 31.10.2019 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2007079183 (ANTHROGENESIS CORP [US], et al) [X] 1-13 * paragraphs [0020] - [0031] * * examples 1-5 *; | [X]WO2008036374 (MEDISTEM LAB INC [US], et al) [X] 1-13 * paragraph [0038] * * examples 4-7 *; | [X]WO2008066330 (MEDIPOST CO LTD [KR], et al) [X] 1-13* claims 1-7 *; | [X]WO2009037690 (PLURISTEM LTD [IL], et al) [X] 1-13 * table 5 * * claims 1-26 *; | [X]US2010047214 (ABRAMSON SASCHA D [US], et al) [X] 1-13 * paragraph [0280] * * claims 1-26 *; | [X]US2010124569 (ABBOT STEWART [US], et al) [X] 1-13 * paragraphs [0055] - [0064] * * claims 1-38 *; | [X]US2011250182 (ABBOT STEWART [US], et al) [X] 1-13 * paragraphs [0136] , [0159] - [0164] * * claims 1-20 *; | [X] - P. DANIELI ET AL, "Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta", EUROPEAN HEART JOURNAL, (20130802), vol. 34, no. suppl 1, doi:10.1093/eurheartj/eht309.P3271, ISSN 0195-668X, pages P3271 - P3271, XP055479184 [X] 1-13 * the whole document * DOI: http://dx.doi.org/10.1093/eurheartj/eht309.P3271 | [X] - H-M YUN ET AL, "Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer's disease", CELL DEATH AND DISEASE, (20130101), vol. 4, no. 12, doi:10.1038/cddis.2013.490, page e958, XP055331815 [X] 1-13 * the whole document * DOI: http://dx.doi.org/10.1038/cddis.2013.490 | International search | [Y]US2006234376 (MISTRY SANJAY [US], et al) [Y] 9-11 * See abstract; claim 30; and paragraph [0021]. *; | [Y]US2012177616 (SERIKOV VLADIMIR B [US], et al) [Y] 12-13* See abstract; and claims 1, 12, 20. *; | [Y]US2014234277 (KIHM ANTHONY J [US], et al) [Y] 6-8 * See abstract; and claims 1, 12-13. *; | [XYA] - JOHNSON, EGIL et al., "Human Umbilical Vein Endothelial Cells Synthesize Functional C3, C5, C6, C8 and C9 In Vitro", Scandinavian Journal of Immunology, (19910630), vol. 33, no. 6, pages 667 - 671, XP055439058 [X] 1, 4-5 * See abstract; page 667, right column, lines 1-11; page 670, left column, lines 11-17 and 22. * [Y] 2, 6-13 [A] 3 DOI: http://dx.doi.org/10.1111/j.1365-3083.1991.tb02539.x | [Y] - BRFVIARIO, FERRUCCIO et al., "Interleukin-1-inducible Genes in Endothelial Cells", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (19921105), vol. 267, no. 31, pages 22190 - 22197, XP 002259793 [Y] 2 * See abstract; page 22193, left column, lines 14-25; and figure 3. * |